Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis-Reference-Cited by-同舟云学术

Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis

Published:2023-07-11 Issue:4 Volume:30 Page:416-423
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Marchi Francesco¹,Kessler Chiara²,Distefano Daniela³,Terzi di Bergamo Lodovico⁴,Fumagalli Luca¹,Averaimo Manuela⁵,Crupi Emanuele²,Bergamini Fabio²,Melli Giorgia⁶⁷,Stussi Georg²⁷,Rossi Davide²⁴⁷,Gobbi Claudio⁶⁷,Ripellino Paolo⁶⁷,Pravatà Emanuele³⁷,Kuhlen Dominique E.¹,Röcken Christoph⁸,Scarone Pietro¹,Gerber Bernhard²⁹,Condoluci Adalgisa²⁴

Affiliation:

1. Neurosurgical Service, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland

2. Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland

3. Department of Neuroradiology, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland

4. Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland

5. Cardiocentro Ticino, Ente Ospedaliero Cantonale, Lugano, Switzerland

6. Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland

7. Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland

8. Department of Pathology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany

9. Faculty of Medicine, University of Zurich, Zurich, Switzerland

Funder

Pfizer

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2023.2230516

Reference30 articles.

1. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

2. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons

3. Management of AL amyloidosis in 2021+

4. Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis

5. Epidemiology of Cardiac Amyloidosis–Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States